A Study of DM001 in Patients With Advanced Solid Tumors

NCT06475937 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms
Carcinoma, Non-Small-Cell Lung
Solid Carcinoma

Interventions

DRUG: DM001

Sponsor

Xadcera Biopharmaceutical (Suzhou) Co., Ltd.